HOME >> MEDICINE >> NEWS
Experts present new research on the hot topics of aging at GSA's Annual Meeting

Note to Editors: The Gerontological Society of America will host its 2003 Annual Scientific Meeting in San Diego, CA, November 21-25. The following is a sampling of the more than 400 sessions scheduled for the five-day conference. Dates and times of the sessions described are in italics. Members of the press may register and customize their own schedule by visiting http://www.eshow2000.com/geron/about_the_meeting.cfm.

Increasing Life Expectancy: The subject of anti-aging is perhaps the most publicly sought-after gerontology news topic today. How far can science extend the human lifespan? This question is due to be answered during one of the over 400 presentations at The Gerontological Society of America's annual meeting. The particular matter of human longevity will be addressed during a symposium consisting of four 20-minute talks, including presentations from biologists Leonard Hayflick and Caleb Finch and demographers James Vaupel and James Carey. They are slated to present the GSA audience with hard, baseline information about current U.S. and worldwide trends in life expectancy and life span, as well as a synopsis of recent developments and/or breakthroughs in the biology of aging.
November 24 at 3:30 p.m.

The Fountain of Youth: The seriousness of the aforementioned extension of the human lifespan will be tackled in GSA's Public Policy Committee symposium, titled "The Genie's Out of the Bottle: Moral, Ethical, and Societal Implications of the Search for the Fountain of Youth." It begins with a review of the great strides that biological research on aging has made in the last two decades, and the possibility of a drug for life-extensions. Next it presents a humanistic exploration of whether decelerating or arresting aging would be an assault on human dignity. Then it considers the professional ethical issues that effective anti-aging
'"/>

Contact: Todd Kluss
tkluss@geron.org
202-842-1275
The Gerontological Society of America
24-Sep-2003


Page: 1 2 3 4

Related medicine news :

1. Experts debate benefits, dangers of chlorine in C&EN point-counterpoint
2. Experts to discuss new advances in IBS therapy and its affect on IBS sufferers
3. Experts to discuss emerging technologies in GI diagnosis and treatment
4. Experts to discuss the affects of non-steroidal anti-inflammatory drugs (NSAIDs)
5. Experts welcome major reforms to the coroners service
6. Experts meet to challenge approaches of testing and developing cancer treatments
7. Experts highlight cardiovascular and drug interaction risks in elderly patients
8. Experts gathering to discuss tapping into $40-$50 billion natural products market
9. Experts recommend increased funding, focus on resuscitation science
10. Experts announce global antimicrobial resistance initiative - World preview of the Global White Paper on bacterial resistance in respiratory tract infections - a call for concerted international action
11. Heart Experts Call For Action Against Missed Opportunities To Prevent Heart Disease In Women

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Experts present new research the hot topics aging GSA Annual Meeting

(Date:4/14/2014)... been made in chemotherapy over the past decade, but ... continues to be a major challenge. , Nanotechnology ... the use of nanocarriers, or capsules, that can transport ... body. , The catch? These carriers are tiny, and ...
(Date:4/14/2014)... the 20th century, is currently losing a lot of ... at the University of South Carolina have just reported ... against so-called "superbugs." , Bacteria have been chipping away ... since their first wide-scale use as antibiotics in the ...
(Date:4/14/2014)... web information on colorectal cancer is too difficult for ... appropriate risks to and concerns of patients, a study ... a review of a dozen popular websites, most of ... were written beyond the recommended sixth-grade reading level, while ...
(Date:4/14/2014)... Inc., announced today a publication demonstrating that the company,s ... cells exposed to plasma samples of patients with a ... "TNT003, an inhibitor of the serine protease C1s, prevents ... was published on-line in the journal Blood ...
(Date:4/14/2014)... Child Development Institute have released their new study of ... success in kindergarten. According to FPG,s report, students enrolled ... of learning. , "Children are progressing at an ... than expected for normal developmental growth," said senior scientist ...
Breaking Medicine News(10 mins):Health News:Nano shake-up 2Health News:Penicillin redux: Rearming proven warriors for the 21st century 2Health News:Penicillin redux: Rearming proven warriors for the 21st century 3Health News:Website information on colon cancer too complex, fails to address key concerns 2Health News:Website information on colon cancer too complex, fails to address key concerns 3Health News:Ex vivo efficacy of C1s antibody as Complement inhibitor in cold agglutinin disease 2Health News:Study gives high marks to NC Pre-K program 2
(Date:1/15/2014)... , Jan. 15, 2014  Manufacturers, suppliers and distributors ... able to protect their most important business assets, ... ) Because of the highly-competitive ... remains one of the most litigious industry sectors ...
(Date:1/15/2014)... 2014 MultiCell Technologies, Inc. (OTC Bulletin Board: ... application concerning composition of matter, biological targets, mechanism of ... death.  This patent application describes a ... molecules (VSRNAs) which interfere with the basic homeostatic cellular ...
(Date:1/15/2014)... 2014  According to Millennium Research Group (MRG), the ... the United States and European ... expand moderately through 2022, with embolization particles representing ... interest in drug-eluting beads (DEBs) and radioembolization spheres ...
Breaking Medicine Technology:Intellectual Property Insurance for Medical-related Products and Services 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
Cached News: